Rehabilitation Through Hippotherapy for the Management of Women After Primary Treatment of Breast Cancer

Summary

Breast cancer is the most common women's cancer and the third leading cause of death. Advances in prevention, detection and primary treatment have improved overall survival leading to its growing acceptance as a long-term disease. Following the announcement of breast cancer, but also after primary treatment, some symptoms appear directly compromising psychic and physical spheres. Hippotherapy is an emerging specialized rehabilitation approach performed through specially trained horses by accredited health professionals. The proposed hippotherapy program offers key elements for physical, psychic and social reinforcement, complementing conventional care. The aim is to provide patients with tools to consolidate their self-awareness and thus strengthen their ability to cope with the disease.

Conditions

• Breast Cancer Female
• Side Effects
• Psychological Distress
• Physical Disability

Interventions

OTHER

Hippotherapy

The horse is an excellent collaborator in situations of physical and mental disability, whether temporary or consolidated. It provides support to humans towards an impairment (anatomical or physiological), a disability, or a restriction of participation as defined by the WHO in 2001. Hippotherapy has a direct action on the sensorimotor capacities of the individual but also on their cognitive capacities, such as attention, memory, psychomotricity, emotions, perceptions, the sequencing of complex movements, or the experience of oneself and the functions of time. Overall, the strong demand from the sensitive, sensory and motor spheres promotes and interacts with the mechanisms linked to the execution of tasks in the cognitive domain (memory, attention, executive functions, speed of information processing, etc.) through the interactions of several neural networks.

OTHER

Conventional therapy

Personalized care pathway after/during the cancer treatment takes into consideration all aspects of the disease, allowing to coordinate the intervention of the professionals that the patient might need in order to better preserve her quality of life while answering questions about cancer, prevention, treatments, or life after illness. The MIS mobilizes a chain of skills and support by providing patients: radiologists, pathologists, surgeons, oncologists, and radiation therapists, nuclear doctors, physiotherapists, cardiologists, psychologists, psychiatrists, nurses, social workers, nutritionists, dieticians, onco-geneticists, osteopaths, homeopaths, acupuncturists, sexologists, addictologists, algologists, and vascular physicians.

Sponsors & Collaborators

• Institut Equiphoria - La Canourgue, France

  collaborator UNKNOWN

• Montpellier Institut du Sein - Montpellier, France

  collaborator UNKNOWN

• Clinique Clementville - Montpellier, France

  collaborator UNKNOWN

• Klésia Languedoc Service de l'Action Sociale - France

  collaborator UNKNOWN

• Fondation Crédit Agricole Solidarité et Développement - France

  collaborator UNKNOWN

• Crédit Agricole du Languedoc - France

  collaborator UNKNOWN

• Alliance Equiphoria

  lead OTHER

Principal Investigators

• Manuel Gaviria, MD, PhD · Alliance Equiphoria

Study Design

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

80 Years

Sex

FEMALE

Healthy Volunteers

No

Timeline & Regulatory

Start

2017-04-20

Primary Completion

2022-08-30

Completion

2022-08-30

Countries

• France

Study Locations